Introduction Since their emergence, SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.351
have spread worldwide. We estimated the risk of hospitalisation and admission to an …

Objectives We estimated the length of stay (LoS) in hospital and the intensive care unit (ICU)
and risk of admission to ICU and in-hospital death among COVID-19 patients ≥18 years in …

Objectives To estimate the risk of hospitalization among reported cases of the Delta variant
of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) compared with the Alpha …

Background: Norway introduced routine rotavirus immunization for all children born on or
after September 1, 2014. We estimated the healthcare burden of all-cause gastroenteritis and …

The COVID-19 pandemic has put unprecedented strain on health systems around the world,
and the emergence of variants of concern (VOC) remains an area of substantial concern as …

Background Rotavirus vaccination was included into the Norwegian childhood immunisation
programme in 2014. Before implementation, rotavirus vaccination was found to be cost–…

Background Currently Norway does not recommend universal varicella vaccination for
healthy children. This study assessed susceptibility to varicella-zoster virus (VZV) in the …

At the end of 2022 and most notably during the first half of 2023, the number of invasive
group A streptococcus (iGAS) notifications increased in Norway, largely affecting children …

Background To minimise vaccine-associated risk of intussusception following rotavirus
vaccination, Norway adopted very strict age limits for initiating and completing the vaccine series …

Background: Use of rotavirus vaccines worldwide since 2006 has led to a significant impact
on the burden of rotavirus disease. However, only a third of European countries have …